SMSNA Meeting

Engy Habashy, MD, discusses key takeaways from the 2025 AUA GSM guideline, including the role of androgens and hormonal therapies in managing genitourinary syndrome of menopause.

Melissa Hadley Barrett discusses real-world outcomes and tolerability of intranasal vardenafil for men with persistent erectile dysfunction despite prior standard therapy.

Juan J. Andino, MD, MBA, discusses surgical decision-making in prolonged ischemic priapism and how ischemia duration affects erectile dysfunction risk and treatment timing.

Data suggested that most patients do not have a preference on the gender of the urologist who is providing their vasectomy care.

Discover innovative approaches to treating premature ejaculation with insights from leading experts in sexual health and urology.

Ellen Cahill, MD, discusses a recent study on testosterone usage among men interested in fertility.

"This has been exciting from a physician-surgeon standpoint," says Helen L. Bernie, DO, MPH.

"I think what we definitively have is a device that's been around for over 50 years now that now we know significantly improves quality of life," says Andrew C. Peterson, MD, MPH.

"We found that the new TENACIO pump was able to complete tasks faster and more efficiently compared to the older MS pump," says Justin Lee, MD.

"I cannot wait to see what the SMSNA is going to have in store next year," says Helen L. Bernie, DO, MPH.

"The biggest complaint we saw, as far as negative outcomes, was loss of length," says Landon Trost, MD.

"The most significant rate of burnout has increased in female urologists," says Marah C. Hehemann, MD.

"What we found [with] 78 patients [was] that patient satisfaction was the same whether you place it in the prevesical space or the ectopic space," says Mohit Khera, MD, MBA, MPH.

"This study is significant because it really emphasizes the importance of early detection of both BPH and ED, because knowing that information can really preserve men's quality of life," says Olivia Paulsen.

"We found an increased association with AKI or acute kidney injury in the group receiving testosterone replacement therapy," said Evan Panken, MD.

None of the videos mentioned the long-term impact of exogenous testosterone on spermatogenesis.

Bajic summarizes his 2024 Sexual Medicine Society of North America Fall Scientific Meeting talk “Penile Prosthesis Biofilms: Friend or Foe?”

"What we found is that costs have really dramatically decreased year by year for all 3 medications," says Ellen Cahill, MD.

Almost all studies (93.5%) reported an improvement in validated patient-reported outcomes following treatment.

"I think patient preference is going to be the most important thing here," says Raevti Bole, MD.

SMSNA 2024 abstract data show shockwave therapies and platelet-rich plasma, either alone or in combination, may be promising treatments for ED.

68.8% of patients had at least a 30% improvement in ventral curvature from baseline.

“The take-home message…is it doesn't matter whether you put the reservoir in the ectopic location or the prevesical location. Patients tend to be satisfied in both locations,” said Mohit Khera, MD, MBA, MPH.

"We're also dealing with some cultural biases, and we have to be mindful [of] how do people like to discuss sexual medicine, and how does that impact our patient interactions?" says Denise Asafu-Adjei, MD, MPH.

The investigators reported a significantly greater prevalence of ED in men with BPH (P < .0001).

"Having a digital footprint is one of the most important things we can do as health care providers," says Amy Pearlman, MD.

"I think it's great, actually, that finally, we have more data on nutrition that we can recommend to our patients," says Stacy Loeb, MD, MSc, PhD (hon).

“Allowing these women to have a fulfilling life after cancer is one of the best things we can do as physicians,” says Talia A. Helman, MD.

"Looking at the survey results, we found that about 40% of men under the age of 40 are interested, at least, in supplementing their testosterone," says Justin Dubin, MD.

For the survey question “Do 5-ARIs reduce serum PSA?” 8 (9.4%) respondents said “no” and 25 (29.4%) said “not sure.”